Uriach
Private Company
Funding information not available
Overview
Uriach is a 185-year-old, privately-held Spanish company that has evolved into the European leader in the Natural Consumer Healthcare segment. It generates significant revenue (€476M) through a house-of-brands strategy, marketing over 20 established brands like Aquilea, Fisiocrem, and Biodramina across categories such as sleep, joint health, digestion, and respiratory care. The company's core strategy combines natural product expertise with scientific validation, supported by a direct commercial footprint and a commitment to sustainability as a B Corp, positioning it for continued European expansion and potential global growth.
Technology Platform
Integrated expertise in phytopharmaceuticals and nutraceuticals, combining traditional knowledge of medicinal plants with modern scientific validation, formulation, and clinical testing for natural active ingredients.
Opportunities
Risk Factors
Competitive Landscape
Uriach competes in the crowded Natural Consumer Healthcare space against large players like Bayer (Consumer Health), GSK (Haleon), and Perrigo, as well as specialized nutraceutical companies and pure-play herbal brands. Its key competitive advantages are its deep heritage in medicinal plants, a large portfolio of established brands, a direct commercial footprint in Europe, and its authentic B Corp sustainability positioning.